Altmann, P., Cunningham, J., Dhanesha, U.
et al (1999) Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. British Medical Journal, 319, 807–811.
Beard, C. M., Waring, S. C., O'Brien, P. C.
et al (1998) Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case–control study in Rochester, Minnesota, 1980 through 1984. Mayo Clinic Proceedings, 73, 951–955.
Breteler, M. M. B., van Swieten, J. C. & Bots, M. L. (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population based study: The Rotterdam Study. Neurology, 44, 1246–1252.
Brookes, A. J., Howell, W. M., Woodburn, K.
et al (1997) Presenilin-1, presenilin-2 and VLDL-R associations in early onset Alzheimer's disease. Lancet, 350, 336–337.
Chen, P., Ganguli, M., Mulsant, B. H.
et al (1999) The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Archives of General Psychiatry, 56, 261–266.
Desmond, D. W., Tatemichi, T. K., Paik, M.
et al (1993) Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke free cohort. Archives of Neurology, 50, 162–166.
Forette, F., Seux, M. L., Staessen, J. A.
et al (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet, 352, 1347–1351.
Gao, S., Hendrie, H. C., Hall, K. S.
et al (1998) The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Archives of General Psychiatry, 55, 809–815.
Gerdes, L. U. (1994) Genotype and cardiovascular disease: a quantitative overview of 42 studies. Genetic Epidemiology, 11, 294.
Gorelick, P. B. (1997) Status of risk factors for dementia associated with stroke. Stroke, 28, 459–463.
Haan, J., Lanser, J. B. K., Zijderveld, I.
et al (1990) Dementia in hereditary cerebral haemorrhage with amyloidosis-Dutch type. Archives of Neurology, 47, 965–967.
Hebert, R. & Brayne, C. (1995) Epidemiology of vascular dementia. Neuroepidemiology, 14, 240–257.
Isoe-Wada, K., Maeda, M., Yong, J.
et al (1999) Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. European Journal of Neurology, 4, 431–435.
Jellinger, K., Danielczyk, W., Fischer, P.
et al (1990) Clinicopathological analysis of dementia disorders in the elderly. Journal of Neurological Sciences, 95, 239–258.
Jorm, A. F., Korten, A. E. & Henderson, A. S. (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica, 76, 465–479.
Joutel, A., Vahedi, K., Corpechot, C.
et al (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet, 350, 1511–1515.
Kalmijn, S., Launer, L. J., Ott, A.
et al (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology, 42, 776–782.
Kawas, C., Resnick, S., Morrison, A.
et al (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology, 48, 1517–1521.
Kehoe, P. G., Russ, C., McIlroy, S.
et al (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nature Genetics, 21, 71–72.
Launer, L. J., Andersen, K., Dewey, M. E.
et al (1999) Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology, 52, 78–84.
Lenzen, H. J., Assman, G., Buchwalsky, R.
et al (1986) Association of apolipoprotein E polymorphism, low density lipoprotein cholesterol and coronary artery disease. Clinical Chemistry, 32, 778–781.
Lerner, A. J. (1999) Alzheimer's disease in males: endocrine issues and prospects. Journal of Clinical Endocrinology and Metabolism, 84, 3416–3419.
Lindsay, J., Hebert, R. & Rockwood, K. (1997) The Canadian Study of Health and Aging – Risk Factors for Vascular Dementia. Stroke, 28, 526–530.
Loeb, C., Gandolfo, C., Croce, R.
et al (1992) Dementia associated with lacunar infarction. Stroke, 23, 1225–1229.
McLachlan, D. R., Bergeron, C., Smith, J. E.
et al (1996) Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology, 46, 401–405.
Meyer, J. S., Judd, B. W., Tawakina, T.
et al (1986) Improved cognition after control of risk factors for multi-infarct dementia. Journal of the American Medical Association, 256, 2203–2209.
Meyer, J. S., McClintik, K., Rogers, R. L.
et al (1988) Aetiological considerations and risk factors for multi-infarct dementia. Journal of Neurology and Neurosurgical Psychiatry, 51, 1489–1497.
Miyos, S., Takano, A., Teramoto, J.
et al (1992) Leukoariosis in relation to prognosis for patients with lacunar infarction. Stroke, 233, 1434–1438.
Moroney, J. T., Tang, M.-X., Bergkind, L.
et al (1999) Low density lipoprotein cholesterol and the risk of dementia with stroke. Journal of the American Medical Association, 282, 254–260.
Mulnard, R. A., Cotman, C. W., Kawas, C.
et al (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Journal of the American Medical Association, 283, 1007–1015.
Okuizumi, K., Onodera, O., Namba, Y.
et al (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genetics, 2, 207–209.
Ott, A., Breteler, M. M. B., de Bruyne, M.C.
et al (1997) Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke, 28, 316–321.
Ott, A., van Rossum, C. T., van Harskamp, F.
et al (1999) Education and the incidence of dementia in a large population-based study: the Rotterdam Study. Neurology, 52, 663–666.
Peerson, G. & Skoog, I. (1996) A prospective population study of psychosocial risk factors for late-onset dementia. International Journal of Geriatric Psychiatry, 11, 15–22.
Pericak-Vance, M. A. & Haines, J. L. (1995) Genetic susceptibility to Alzheimer disease. Trends in Genetics, 11, 504–508.
Rocca, W. A., van Duijn, C. M., Clayton, D.
et al (1991) Maternal age and Alzheimer's disease: a collaborative re-analysis of case–control studies. EURODEM Risk Factors Research Group. International Journal of Epidemiology, 20 (suppl. 2), S21–S27.
Sano, M., Ernesto, C., Thomas, R. G.
et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. New England Journal of Medicine, 336, 1216–1222.
Skoog, I., Lernfelt, B., Landahl, S.
et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet, 347, 1141–1145.
Stewart, R., Prince, M. & Mann, A. (1999) Vascular risk factors and Alzheimer's disease. Australian and New Zealand Journal of Psychiatry, 33, 809–813.
Tatemichi, T. K., Desmond, D. W., Mayeux, R.
et al (1992) Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology, 42, 1185–1193.
Tatemichi, T. K., Desmond, D. W., Paik, M.
et al (1993) Clinical determinants of dementia related to stroke. Annals of Neurology, 33, 568–575.
Yaffe, K., Blackwell, T., Gore, R.
et al (1999) Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Archives of General Psychiatry, 56, 425–430.